AMPK regulates hepatic lipid metabolism through the phosphorylation of ACC and activation of PPARα that leads to an inhibition of hepatic de novo lipogenesis and stimulation of fatty acid oxidation, representing key aspects in NAFLD pathogenesis18–24. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.